相关实验视频

Updated: Jul 16, 2025

Manganese Oxide Nanoparticle Synthesis by Thermal Decomposition of ManganeseII Acetylacetonate

Manganese Oxide Nanoparticle Synthesis by Thermal Decomposition of ManganeseII Acetylacetonate

Published on: June 18, 2020

基于的纳米系统在癌症放射治疗中的治疗应用

Shuya Pan¹, Zhengwei Sun¹, Bo Zhao¹

¹Zhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, China.

|September 18, 2023

概括

基于的纳米材料通过克服瘤微环境挑战,如缺氧和高谷氨,增强癌症放射治疗. 这些纳米系统提高了治疗效率,并为精密治疗提供了潜力.

科学领域:

生物医学工程生物医学工程
纳米技术纳米技术
在瘤学瘤学.

背景情况:

放射治疗是一种关键的癌症治疗方法,但其有效性受到瘤微环境 (TME) 的限制.
瘤特征,如缺氧和高谷氨 (GSH) 水平阻碍了放射治疗的结果.
基于 (Mn) 的纳米材料在克服这些TME限制方面表现有前途.

研究的目的:

审查基于Mn的纳米系统使放射治疗敏感的机制.
探索基于Mn的放射性敏感剂在癌症治疗中的应用.
讨论基于的纳米系统在精密放射治疗中的作用和未来的临床挑战.

主要方法:

文献综述,重点关注基于Mn的纳米材料及其放射敏感性.
分析包括低氧缓解,活性氧物种 (ROS) 生成,GSH转化和免疫反应调节在内的机制.
检查放射敏感剂开发,药物输送,组合疗法和成像中的应用.

主要成果:

基于Mn的纳米系统有效地减轻瘤缺氧并增加ROS的产生.
这些纳米材料促进了GSH转化,增强了辐射敏感性.
基于Mn的系统可以促进抗瘤免疫力,并作为精密治疗的对比剂.

结论:

基于Mn的纳米系统提供了多方面的策略,通过向TME来提高放射治疗的疗效.
它们的应用范围从放射敏感剂开发到实现精确的癌症治疗.
需要进一步的研究,以应对成功临床转化基放射性敏感剂的挑战.

关键词:

癌症治疗治疗癌症治疗是一种.纳米系统纳米系统辐射疗法辐射疗法

更多相关视频

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

相关概念视频

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...